Smith & Nephew tops 2023 goals, projects continued growth

Medical device manufacturer Smith & Nephew (LSE: SN) surpassed both internal targets and analyst expectations, reporting strong annual results for 2023. Revenue climbed 6.4% to $5.55 billion, exceeding guidance and analyst estimates. Trading profit also … Read more